Europe Pediatric Perfusion Market Introduction and Overview
According to SPER Market Research, the Europe Pediatric Perfusion Market is estimated to reach USD XX billion by 2033 with a CAGR of 5.81%.
The report includes an in-depth analysis of the Europe Pediatric Perfusion Market, including market size and trends, product mix, applications, and supplier analysis. During open heart surgery, pediatric perfusion attends to the respiratory and circulatory requirements of the young patient. During surgery, a child's blood circulation and oxygenation are supported with pediatric perfusion devices. During a surgical treatment, these devices make sure that the child's important organs receive oxygen and nourishment. Pediatric perfusion pumps are essential for treating a number of congenital cardiac conditions. Surgery may be necessary to correct these anomalies, which can range in severity from minor to severe. There are several different kinds of pediatric perfusion devices on the market, including cardiac monitors, blood pumps, pediatric cannulas, heart-lung machines, and oxygenators.
- March 2023; Established in the UK, LivaNova is a medical device firm that received approval from the US food and Drug Administration to introduce Essenz Heart Lung Machine in the US market. The Essenz Heart Lung Machine and the LivaNova patient monitor work together to create the perfusion system that is utilized during cardiopulmonary bypass procedures.
Market Opportunities and Challenges
Opportunities- The pediatric perfusion industry offers a lot of opportunities, especially for equipment invention and development that is smaller in size. These devices offer more accurate control and fewer problems, making them more suitable for the physiological requirements of newborns and babies. This constitutes a noteworthy progression in the field of juvenile cardiac treatment, presenting a compelling prospect for industry participants. In emerging nations, where access to pediatric cardiac care is improving and the healthcare infrastructure is growing, there is also room for expansion. The increasing need for healthcare services in these areas may encourage the growth of the market.
Challenges- The market for pediatric perfusion faces a number of difficulties, including the sometimes drawn-out and complicated process of regulatory compliance and approval. Financial constraints arise due to the high cost of new medical equipment, particularly for smaller healthcare facilities. Staffing problems are made worse by the shortage of pediatric perfusionists with specific training. The picture is further complicated by strict standards for clinical trials and testing, ethical considerations, and parental approval. Equal access to cutting-edge treatments is further hampered by regional differences in healthcare infrastructure and financial limitations. Complexity is increased by lack of consistency in treatment protocols, technological obstacles, and integration challenges. To provide the best possible care, healthcare providers' awareness and education also require a great deal of progress.
Market Competitive Landscape
A lot of companies are focusing on organic growth strategies, such as product launches, approvals, and other techniques including patents and events. The market witnessed the following inorganic growth strategies: partnerships, acquisitions, and collaborations. The major players in the market are BL Lifesciences, Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), GE HealthCare Technologies, Inc., Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nonin Medical, Inc., and Terumo Corporation.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Application, By End-Use
|
| Regions covered | Eastern Europe, Southern Europe, Western Europe, and Northern Europe
|
| Companies Covered | BL Lifesciences, Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), GE HealthCare Technologies, Inc., Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nonin Medical, Inc., and Terumo Corporation.
|
COVID-19 Impact on Europe Pediatric Perfusion Market
Due to the cancellation or postponement of elective cardiac procedures, the COVID-19 pandemic temporarily hurt the business. Additionally, as the number of COVID cases increased, attention was diverted from paediatric patients in need to COVID cases at that particular moment. However, it was anticipated that the industry would pick up steam when things get better and the healthcare systems bounce back. As a result of hospitals allocating resources to address the rise in COVID-19 cases, pediatric perfusion systems were less accessible and used.
Key Target Audience:
- Pediatric Cardiology Centers
- Pediatric Intensive Care Units (PICUs)
- Children’s Hospitals
- Academic and Research Institutions
- Healthcare Providers and Professionals
- Parent and Patient Advocacy Groups
Our in-depth analysis of the Europe Pediatric Perfusion Market includes the following segments:
|
By Product:
|
Oxygenators
Cannulas and Catheters
Blood Pumps
Arterial Filters
|
|
By Application:
|
Cardiac Surgeries
Organ Transplantation
|
|
By End-Use:
|
Hospitals
Cardiac Centers
|
Key Topics Covered in the Report:
- Europe Pediatric Perfusion Market Size (FY’2024-FY’2033)
- Overview of Europe Pediatric Perfusion Market
- Segmentation of Europe Pediatric Perfusion Market By Product (Oxygenators, Cannulas and Catheters)
- Segmentation of Europe Pediatric Perfusion Market By Application (Cardiac Surgeries, Organ Transplantation)
- Segmentation of Europe Pediatric Perfusion Market By End-Use (Hospitals, Cardiac Centers)
- Statistical Snap of Europe Pediatric Perfusion Market
- Expansion Analysis of Europe Pediatric Perfusion Market
- Problems and Obstacles in Europe Pediatric Perfusion Market
- Competitive Landscape in the Europe Pediatric Perfusion Market
- Impact of COVID-19 and Demonetization on Europe Pediatric Perfusion Market
- Details on Current Investment in Europe Pediatric Perfusion Market
- Competitive Analysis of Europe Pediatric Perfusion Market
- Prominent Players in the Europe Pediatric Perfusion Market
- SWOT Analysis of Europe Pediatric Perfusion Market
- Europe Pediatric Perfusion Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Pediatric Perfusion Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Pediatric Perfusion Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Pediatric Perfusion Market
7. Europe Pediatric Perfusion Market, By Product (USD Million) 2020-2033
7.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By Product, 2020-2026
7.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By Product, 2027-2033
7.3. Oxygenators
7.4. Cannulas and Catheters
7.5. Blood Pumps
7.6. Arterial Filters
8. Europe Pediatric Perfusion Market, By Application (USD Million) 2020-2033
8.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By Application, 2020-2026
8.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By Application, 2027-2033
8.3. Cardiac Surgeries
8.4. Organ Transplantation
9. Europe Pediatric Perfusion Market, By End-Use (USD Million) 2020-2033
9.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By End-Use, 2020-2026
9.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By End-Use, 2027-2033
9.3. Hospitals
9.4. Cardiac Centers
10. Europe Pediatric Perfusion Market Forecast, 2020-2033 (USD Million)
10.1. Europe Pediatric Perfusion Market Size and Market Share
11. Europe Pediatric Perfusion Market, By Region, 2020-2033 (USD Million)
11.1. Europe Pediatric Perfusion Market Size and Market Share By Region (2020-2026)
11.2. Europe Pediatric Perfusion Market Size and Market Share By Region (2027-2033)
11.3. Eastern Europe
11.4. Southern Europe
11.5. Western Europe
11.6. Northern Europe
12. Company Profile
12.1. BL LIFESCIENCES
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. CARDINAL HEALTH, INC
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. EUROSETS S.R.L (GVM CARE RESEARCH)
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. GE HEALTHCARE TECHNOLOGIES, INC
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. GETINGE AB12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. KONINKLIJKE PHILIPS N.V.
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. LIVANOVA PLC
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. MEDTRONIC PLC
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. NONIN MEDICAL, INC
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. TERUMO CORPORATION
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. OTHERS
13. Conclusion
14. List of Abbreviations
15. Reference Links